German Pharmaceuticals & Biotech Most Popular Stocks

Merck KGaA

Market Cap: €46.7b

Operates as a science and technology company in Germany.

Bayer

Market Cap: €27.2b

Operates as a life science company worldwide.

SCHOTT Pharma KGaA

Market Cap: €3.2b

Develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharmaceutical, biotechnology, and life science industries worldwide.

Dermapharm Holding

Market Cap: €1.7b

Manufactures and sells off-patent branded pharmaceutical products in Germany, France, Spain, Austria, Switzerland, and internationally.

Gerresheimer

Market Cap: €1.2b

Provides medicine packaging, drug delivery devices, and solutions in Germany and internationally.

Evotec

Market Cap: €1.1b

Operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally.

Hamlet BioPharma

Market Cap: €999.0m

Engages in the development of drugs for the treatment and prevention of cancer in Sweden.

PEPTONIC medical

Market Cap: €560.2m

A pharmaceutical company, researches, develops, and sells medical treatments and lifestyle products in the field of women's health.

Formycon

Market Cap: €397.4m

A biotechnology company, develops biosimilar drugs in Germany and Switzerland.

PharmaSGP Holding

Market Cap: €354.6m

Manufactures and sells over-the-counter drugs and other healthcare products in Germany.

Dextech Medical

Market Cap: €157.1m

Engages in the development of drug candidates with application in urological oncology, primarily prostate cancer.

Heidelberg Pharma

Market Cap: €138.0m

A biopharmaceutical company, focuses on oncology and antibody targeted amanitin conjugates (ATAC) in Germany, the United States, and internationally.

AcuCort

Market Cap: €135.5m

Develops and commercializes glucocorticoid dexamethasone films for the treatment of acute allergic conditions.

Darwin

Market Cap: €96.0m

Operates as a biotechnology company.

Apontis Pharma

Market Cap: €91.2m

Engages in the marketing and sale of medical drugs for indication fields of internal medicine in Germany.

MPH Health Care

Market Cap: €76.2m

An investment company, engages in the healthcare business in Germany.

2invest

Market Cap: €73.9m

An investment company, acquires, holds, manages, and sells investments in corporations and partnerships primarily in the biotechnology, life science, and IT sectors in Germany and internationally.

Genetic Analysis

Market Cap: €62.2m

A science-based diagnostic company, develops diagnostic solutions for human microbiome market in the United States, Europe, and internationally.

Cantourage Group

Market Cap: €45.6m

Operates as a medical cannabis company in Europe.

Vidac Pharma Holding

Market Cap: €23.2m

An investment holding company, engages in the discovery and development of medicines for oncologic and dermatologic diseases.

SynBiotic

Market Cap: €19.9m

Engages in the research and development, production, and marketing of cannabinoid and terpene-based solutions to for pain, sleep deprivation, and anxiety.

Respiratorius

Market Cap: €19.5m

A research company, develops drug candidates for the treatment of cancer, chronic obstructive pulmonary disease (COPD), and asthma.

Biomark Diagnostics

Market Cap: €18.4m

Develops early-stage cancer diagnostic technology platform to detect and treat cancer.

Biofrontera

Market Cap: €16.5m

A biopharmaceutical company, engages in the research, development, and distribution of dermatological products in Germany, Spain, the United Kingdom, rest of Europe, the United States, and internationally.

Liminal BioSciences

Market Cap: €11.8m

Liminal BioSciences Inc., a development stage biopharmaceutical company, focuses on the development of novel small molecule drug therapeutics for inflammatory, fibrotic, and metabolic diseases in Canada and the United Kingdom.

PExA

Market Cap: €9.4m

Develops and commercializes diagnostic products in various respiratory diseases.

4SC

Market Cap: €9.2m

A biopharmaceutical company, engages in developing small-molecule drugs that address cancer diseases with high unmet medical needs in Germany and internationally.

TFF Pharmaceuticals

Market Cap: €9.7m

A clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform in the United States and Australia.

Vitruvia Medical

Market Cap: €2.3m

A technology company, operates in the healthcare sector.

Medigene

Market Cap: €1.0m

A biotechnology company, focuses on the discovery and development of T-cell therapies for the treatment of cancer.

Cannovum Cannabis

Market Cap: €924.5k

Engages in the manufacturing, wholesaling, and importing of medical cannabis products in Berlin.

Epigenomics

Market Cap: €784.0k

Does not have significant operations.

co.don

Market Cap: €694.8k

Does not have significant operations.

Sangui Biotech International

Market Cap: €419.8k

Through its subsidiaries, engages in the manufacturing and sales of wound treatment and cosmetic products.

INDVR Brands

Market Cap: €314.1k

Provides personnel and management resources, and infrastructure and equipment for use in production, cultivation, and dispensary operations of licensed cannabis businesses in the United States.

bioXXmed

Market Cap: €176.7k

An investment company, invests in biotechnology or medical technology companies with equity or debt capital.